IL6 and Alzheimer disease: Although TSLP and IL-6 are well-recognized pro-inflammatory mediators in AD, particularly as early activators of keratinocyte-immune crosstalk, our data showed that their mRNA expression levels were not significantly reduced following oral administration of sesamin (supplementary Fig. 5).